Biofilm Innovations, Inc., was invented by Dr. Lawrence A. Funt and his son, L. Andrew Funt, President and CEO, in 1999, following their discovery of PAC5® (originally known as Formula A), a unique antimicrobial formulation that, studies have shown, kills biofilm, the known cause of dental infection.
Dr. Funt, a Bethesda, Maryland, orthodontist, received his degree from Georgetown University School of Dentistry and specialized in orthodontics. He was also a pioneer in the “trigger point” method of treating myofascial pain and authored the textbook, “Anatomy of a Headache,” a review of myofascial pain and dysfunction and its treatment, published in 1999.
PAC5® was used to develop a line of oral care products, marketed as EXXCL Oral Blue™, which includes an Oral Irrigant, a Toothpaste, and a Foamer bottle used to fill a 2 mm Bioplast perio-appliance (made in-house or by a dental laboratory) with Oral Irrigant.
Toxicology studies and ingredient content were reviewed by the U.S. Food and Drug Administration, and EXXCL Oral Blue™ products were determined to be FDA compliant.
EXXCL Oral Blue™ products, initially marketed to select dental practices, are now sold nationally and internationally.
The company has now developed an all-natural mouthwash containing PAC5®, EXXCL Oral Clear,™ for the consumer market.
Biofilm Innovations, Inc., is committed to advancing personal and public health and wellness by investigating the possible development of non-invasive, safe products and processes, utilizing PAC5® technology for medical, dental, veterinarian, and industrial applications.
Biofilm Innovations, Inc., is committed to advancing personal and public health and wellness by investigating the possible development of non-invasive, safe products and processes, utilizing PAC5® technology for medical, dental, veterinarian, and industrial applications.
